Dr. med. Dirk Manski

 You are here: Urology Textbook > Prostate > BPH > Surgical treatment

Surgery for Benign Prostatic Hyperplasia (BPH)


Review literature: (Burnett und Wein, 2006) (DGU guideline) (EAU guideline: Non-neurogenic male LUTS)

Transurethral Resection of the Prostate (TURP)

Transurethral resection of the prostate (TURP) is the endoscopic removal of prostate tissue using an electrical wire loop (monopolar or bipolar electrocautery). TURP is the gold standard of invasive therapy for benign prostatic syndrome (BPS) up to a maximum of 75–100 ml prostate volume, accounting for over 90% of all invasive procedures

Schematic drawing of TURP. Ideally, the direct view through the resectoscope is avoided, and a camera system is used. With kind permission, Dr. J. Schönebeck, Ljungby, Schweden.
figure TUIP: transurethral incision of the prostate.

Indications for TURP:

The most common indication for TURP is moderate to severe symptoms of BPH, which cannot be controlled with medication and lower the patient's quality of life. Furthermore, surgical therapy is indicated:

Surgical Technique and Complications of TURP:

Please see section transurethral resection of the prostate (TURP) for details.

Results of TURP:

TURP significantly and persistently improves urinary stream (+160%), IPSS(-70%), quality of life, and residual urine volume (-77%). Voiding symptoms are treated more successfully than storage symptoms. Nocturia is not improved in 20–40%. The data for efficacy and durability from controlled studies is superior and does not exist to this extent for any of the alternative procedures listed below.

Transurethral Incision of the Prostate (TUIP)

Transurethral incision of the prostate (TUIP) leads to desobstruction by incising the bladder neck and prostate tissue.

Indication: well suited for treating small-volume prostates (below 40 ml) and for young patients. Advantages: lower surgical risks (blood loss, TUR syndrome), reduced rate of retrograde ejaculation (0–37%).

Technique: two incisions from the bladder neck to the verumontanum are done at 4 and 8 o'clock with the resectoscope using a hook electrode [figure technique of TUIP].


TUIP: transurethral incision of the prostate. Two incisions from the bladder neck to the verumontanum are done at 4 and 8 o'clock.
figure TUIP: transurethral incision of the prostate.

Endoscopic Enucleation of the Prostate (EEP)

In (anatomical) endoscopic enucleation of the prostate (EEP or AEEP), the entire prostate adenoma is mobilized transurethrally along the pseudocapsule comparable to an open-surgical adenomectomy and removed transurethrally using a morcellator.

Indication:

EEP is an alternative to TURP and to open surgical adenomectomy. With good technical expertise, any prostate volume can be treated effectively.

Surgical technique:

The first incision is done at the apex; then the adenoma is mobilized under direct vision, and different energy techniques are used for cutting:

The prostate adenoma is completely mobilized into the urinary bladder and removed using a morcellator.

Results and complications:

Randomized trials demonstrated comparable efficacy, shorter catheterization times (1–2 days), lower blood loss, and shorter hospital stay compared with TURP or open surgical adenomectomy.

Transurethral Laser Treatment for Benign Prostatic Hyperplasia (BPH)

Different Techniques of Prostate Laser Treatment:

Due to the availability of various laser types with different physical properties, a variety of clinical procedures have been developed:

Transurethral Ultrasound-Guided Laser-Induced Prostatectomy (TULIP):

TULIP is medical history because a direct visualization of the laser effects was impossible.

Visual laser ablation of the prostate (VLAP):

VLAP is medical history. VLAP was a side-fire laser application with tissue coagulation under vision. VLAP leads to necrosis of the adenoma and (later) to symptom improvement. The technique is no longer used due to better alternatives.

Holmium laser enucleation of the prostate (HoLEP):

See the above section: endoscopic enucleation of the prostate (EEP) and section HoLEP.

Transurethral evaporization of the prostate (TUEP):

The high power of the laser application (KTP greenlight or thulium) leads to the vaporization of prostate tissue with good tissue ablation and good coagulation of deeper prostate tissue layers. The treatment can be performed under ongoing anticoagulation, and the risk for TUR syndrome is low. The procedure is particularly suitable for cardiac risk patients. Disadvantages include high equipment and probe costs. For technique and complications, see section Greenlight laser vaporization of the prostate


Transurethral evaporization of the prostate (TUEP) using a greenlight KTP Laser.
figure Transurethral evaporization of the prostate

Results from randomized trials with Laser techniques for BPH:

Of the numerous laser procedures, HoLEP and KTP laser vaporization have stood the test of time. For both procedures, randomized studies are available, which show comparable results and reduced complications in comparison to TURP or transvesical prostatectomy (Kuntz et al., 2004) (Kuntz et al., 2008) (Reich et al., 2011). Laser enucleation is superior to vaporization for prostates with a volume over 60 ml (Elmansy et al., 2012).

Transvesical and Retropubic Open Simple Prostatectomy

Fig. principle of suprapubic simple prostatectomy, transvesical technique initially described by Harris and Hryntschak.
figure: surgical principle of suprapubic transvesical prostatectomy for BPH

Fig. principle of retropubic simple prostatectomy.
figure: surgical principle of retropubic simple prostatectomy for BPH

Indication for adenomectomy:

Simple prostatectomy is indicated in large prostate adenomas over 80–100 ml. Combined open surgical treatment is wise if significant bladder diverticula or bladder stones are present, even with smaller prostate volumes. Other indications for simple prostatectomy are complex urethral diseases (e.g., after hypospadias correction) and existing contraindications to lithotomy position.

Technique and Complications of Simple Prostatectomy:

Suprapubic simple prostatectomy is suitable for significant middle lobe enlargement, treatment of bladder stones, and resection of bladder diverticula. Retropubic simple prostatectomy offers the advantage of better hemostasis and better apical preparation, but it is not ideal with a large median lobe, bladder diseases, or obesity. For a detailed description of the surgical techniques and complications, see section transvesical prostatectomy and retropubic simple prostatectomy.

New Interventional Methods

Prostatic Artery Embolization (PAE)

For many years, prostatic artery embolization has been used to treat macrohematuria due to BPH. Follow-up showed improvement in voiding symptoms in many patients, so PAE is currently used for this indication as well.

Indication:

PAE is an alternative to TURP or adenomectomy for voiding symptoms or recurrent macrohematuria without relevant associated pathology, such as bladder stones or large diverticula.

Technique:

Superselective probing of the prostatic arteries, and injection of small embolization particles with careful sparing of penile or rectal arteries. For successful treatment, bilateral embolization is necessary. In the course, tissue necrosis and prostate volume reduction occur with gradual improvement of voiding symptoms.

Results:

Improvement in micturition symptoms starts after months and may continue to improve in the further course. In comparative studies, TURP was shown to be more effective in improving symptoms, urinary stream, residual urine, prostate volume, and IPSS (Abt et al., 2018) (Ray et al., 2018). PAE has also been used in patients with urinary retention who were unsuitable for TURP, with a success rate of 60%. Long-term results are not available.

Complications:

Diminished ejaculation and dysuria are common. Less common are persistent dysuria, urinary retention (3–7%), high radiation exposure (radiation dermatitis), mis-embolization (urinary bladder, rectum, penis), and complications of angiography.

Transurethral microwave therapy (TUMT)

Transurethral microwave therapy (TUMT) uses microwaves (900–1300 MHz) to heat the prostate tissue to 70 degrees Celsius while a special catheter cools the urethral mucosa. Newer generation devices are, e.g., Prostatron, ProstaLund, and Targis. TUMT leads to heat necrosis, apoptosis, and destruction of adrenergic nerve fibers in the prostate with improved symptoms. TUMT with newer generation devices requires sedation and analgesia.

Indications for TUMT:

TUMT shares the same indications as TURP but is especially suited for patients with higher comorbidity.

Results of TUMT:

Randomized trials show a significant improvement in symptoms, which is not always accompanied by an improvement in objective parameters like maximum urinary flow. There are few side effects; the main complication is the necessity of postoperative long-term catheterization. A significant proportion of patients need different treatment due to treatment failure of TUMT.

Transurethral Needle Ablation of the Prostate (TUNA)

Needle probes are inserted into the adenoma under direct vision (and TRUS imaging), and heat necrosis of the adenoma is induced with microwaves (500 kHz). The technique can be performed under local anesthesia or spinal anesthesia.

Results of TUNA:

The advantage of TUNA is treatment without the need for general anesthesia or hospitalization. The initial postoperative course is characterized by recurrent urinary retention in 13–40% of patients until the necrotic tissue is discharged. The technique is rarely used.

Transurethral Vaporization of the Prostate (TUVP)

Monopolar or bipolar current is used to vaporize the prostatic tissue next to the electrode, while coagulation occurs in deeper tissue planes. The electrodes are a rolling cylinder or a thick resection loop.

Results of TUVP:

Randomized trials demonstrated similar results between TUVP and TURP, without clear clinical benefits for TUVP (a trend towards less blood loss).

Transurethral Urolift procedure

The urolift procedure is a nonablative surgical technique for desobstruction of the prostatic urethra (Berges et al., 2013). The procedure is a minimally invasive treatment option in patients with relative indications for surgery (without urinary retention or recurrent macrohematuria), a prostatic volume less than 60 ml, and no significant middle lobe. Advantages are the low complication rate and the preservation of antegrade ejaculation.

Surgical technique: using an applicator, 2–6 small tissue retractors are inserted transurethrally into the prostate, compressing the prostate tissue and allowing a channel with better flow between the bladder neck and sphincter.

Results: long-term results after five years showed stable improvement in symptom score and urinary flow without a negative impact on sexual function (Roehrborn et al., 2017).

Image-Guided Robot-Assisted Water Jet Prostate Ablation

Transurethral sonography is used to mark the areas of the prostate that are to be ablated. The robotically guided water jet (Aquabeam) removes the tissue within a few minutes (aquablation of the prostate), and hemostasis is achieved either by an irrigation catheter on traction or by subsequent electrocoagulation.

Results: same operating time as TURP; advantages of the procedure are gentle tissue ablation without heat effect. Problematic is the high rate of postoperative bleeding complications, at least without interventional hemostasis after ablation. In prostate glands larger than 100 ml, a transfusion rate of 8% has been reported (Desai et al., 2019). Other disadvantages include numerous exclusion criteria and the lack of histology.

Transurethral Water Vapour Therapy (Rezum)

Under local anesthesia, needles are inserted cystoscopically into the prostate tissue. A heat necrosis of the prostate tissue is created with the help of water vapor. The thermal effect is limited to the prostate.

Results: Rezum is a well-tolerated procedure and preserves sexual function. Randomized results comparing with reference procedures are not available.

Laparoscopic Adenomectomy

Laparoscopic (robotically assisted) adenomectomy uses both transvesical and retropubic surgical techniques. The OR time is significantly higher than with open surgery, but there are advantages in bleeding volume (340 vs. 590 ml) and length of hospital stay (Sorokin et al., 2017). Only a few centers use laparoscopic adenomectomy regularly.






Index: 1–9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

References

Andriole u.a. 2004 ANDRIOLE, G. L. ; ROEHRBORN, C. ; SCHULMAN, C. ; SLAWIN, K. M. ; SOMERVILLE, M. ; RITTMASTER, R. S.: Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia.
In: Urology
64 (2004), Nr. 3, S. 537–41; discussion 542–3

Burnett und Wein 2006 BURNETT, A. L. ; WEIN, A. J.: Benign prostatic hyperplasia in primary care: what you need to know.
In: J Urol
175 (2006), Nr. 3 Pt 2, S. S19–24

Chapple 2004 CHAPPLE, C. R.: Pharmacological therapy of benign prostatic hyperplasia/lower urinary tract symptoms: an overview for the practising clinician.
In: BJU Int
94 (2004), Nr. 5, S. 738–44

DGU Guideline, “S2e Leitlinie Diagnostik und Therapie des Benignen Prostatasyndroms (BPS).,” 2023. [Online]. Available: https://register.awmf.org/assets/guidelines/043-034l_S2e_Diagnostik_Therapie_benignes_Prostatasyndrom_2023-04.pdf

Donovan u.a. 2000 DONOVAN, J. L. ; PETERS, T. J. ; NEAL, D. E. ; BROOKES, S. T. ; GUJRAL, S. ; CHACKO, K. N. ; WRIGHT, M. ; KENNEDY, L. G. ; ABRAMS, P.: A randomized trial comparing transurethral resection of the prostate, laser therapy and conservative treatment of men with symptoms associated with benign prostatic enlargement: The CLasP study.
In: J Urol
164 (2000), Nr. 1, S. 65–70

“EAU Guideline: Non-neurogenic Male LUTS,” Available: https://uroweb.org/guidelines/treatment-of-non-neurogenic-male-luts/.

Kopp, R. P.; Freedland, S. J. & Parsons, J. K. Associations of benign prostatic hyperplasia with prostate cancer: the debate continues.
Eur Urol, 2011, 60, 699-700; discussion 701-2.

Ørsted, D. D.; Bojesen, S. E.; Nielsen, S. F. & Nordestgaard, B. G. Association of clinical benign prostate hyperplasia with prostate cancer incidence and mortality revisited: a nationwide cohort study of 3,009,258 men.
Eur Urol, 2011, 60, 691-698.

Parsons, J. Kellogg; Messer, Karen; White, Martha; Barrett-Connor, Elizabeth; Bauer, Douglas C; Marshall, Lynn M; in Men (MrOS) Research Group, Osteoporotic Fractures & the Urologic Diseases in America Project Obesity increases and physical activity decreases lower urinary tract symptom risk in older men: the Osteoporotic Fractures in Men study.
Eur Urol, 2011, 60, 1173-1180.

Reich u.a. 2006 REICH, O. ; GRATZKE, C. ; STIEF, C. G.: Techniques and long-term results of surgical procedures for BPH.
In: Eur Urol
49 (2006), Nr. 6, S. 970–8; discussion 978

Uygur u.a. 1998 UYGUR, M. C. ; GUR, E. ; ARIK, A. I. ; ALTUG, U. ; EROL, D.: Erectile dysfunction following treatments of benign prostatic hyperplasia: a prospective study.
In: Andrologia
30 (1998), Nr. 1, S. 5–10



  Deutsche Version: Operative Therapie der benignen Prostatahyperplasie